224
Participants
Start Date
August 9, 2024
Primary Completion Date
January 31, 2029
Study Completion Date
August 31, 2029
Heparin
The patients randomized to standard medical care will receive (or continue) either any type of body-weight adjusted low molecular weight heparin in therapeutic dose, or intravenous adjusted dose unfractionated heparin (aPTT value kept within 1 time the normal value), according to the existing international guidelines.
Endovascular treatment
Standard endovascular techniques to mechanically remove clot material, such as mechanical thrombectomy and/or balloon angioplasty and/or local application of alteplase or urokinase within the thrombosed sinuses.
RECRUITING
Beijing Tiantan Hospital, Beijing
Beijing Tiantan Hospital
OTHER